CN101429200B - 用作抗心律失常剂的三环苯并吡喃化合物 - Google Patents

用作抗心律失常剂的三环苯并吡喃化合物 Download PDF

Info

Publication number
CN101429200B
CN101429200B CN2008101707921A CN200810170792A CN101429200B CN 101429200 B CN101429200 B CN 101429200B CN 2008101707921 A CN2008101707921 A CN 2008101707921A CN 200810170792 A CN200810170792 A CN 200810170792A CN 101429200 B CN101429200 B CN 101429200B
Authority
CN
China
Prior art keywords
amino
carbonyl
dihydro
pyrans
alcohol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2008101707921A
Other languages
English (en)
Chinese (zh)
Other versions
CN101429200A (zh
Inventor
生赖一彦
繁田幸宏
上杉理
冈田匠
松田智行
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissan Chemical Corp
Original Assignee
Nissan Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Corp filed Critical Nissan Chemical Corp
Publication of CN101429200A publication Critical patent/CN101429200A/zh
Application granted granted Critical
Publication of CN101429200B publication Critical patent/CN101429200B/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D515/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D515/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Dental Preparations (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN2008101707921A 2004-03-23 2005-03-23 用作抗心律失常剂的三环苯并吡喃化合物 Expired - Fee Related CN101429200B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004084605 2004-03-23
JP084605/2004 2004-03-23

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN2005800090295A Division CN1934116B (zh) 2004-03-23 2005-03-23 用作抗心律失常剂的三环苯并吡喃化合物

Publications (2)

Publication Number Publication Date
CN101429200A CN101429200A (zh) 2009-05-13
CN101429200B true CN101429200B (zh) 2012-05-30

Family

ID=34962589

Family Applications (3)

Application Number Title Priority Date Filing Date
CN2008101707921A Expired - Fee Related CN101429200B (zh) 2004-03-23 2005-03-23 用作抗心律失常剂的三环苯并吡喃化合物
CN2005800090295A Expired - Lifetime CN1934116B (zh) 2004-03-23 2005-03-23 用作抗心律失常剂的三环苯并吡喃化合物
CN2011100751168A Expired - Fee Related CN102190661B (zh) 2004-03-23 2005-03-23 用作抗心律失常剂的三环苯并吡喃化合物

Family Applications After (2)

Application Number Title Priority Date Filing Date
CN2005800090295A Expired - Lifetime CN1934116B (zh) 2004-03-23 2005-03-23 用作抗心律失常剂的三环苯并吡喃化合物
CN2011100751168A Expired - Fee Related CN102190661B (zh) 2004-03-23 2005-03-23 用作抗心律失常剂的三环苯并吡喃化合物

Country Status (30)

Country Link
US (2) US7652008B2 (https=)
EP (1) EP1732929B1 (https=)
JP (1) JP4840594B2 (https=)
KR (2) KR101085979B1 (https=)
CN (3) CN101429200B (https=)
AT (1) ATE485299T1 (https=)
AU (2) AU2005223612B2 (https=)
BR (1) BRPI0508768A (https=)
CA (1) CA2558139C (https=)
CY (1) CY1111250T1 (https=)
CZ (1) CZ2006598A3 (https=)
DE (1) DE602005024245D1 (https=)
DK (1) DK1732929T3 (https=)
EG (1) EG27163A (https=)
ES (1) ES2353021T3 (https=)
HR (1) HRP20110005T1 (https=)
IL (1) IL177950A (https=)
MX (1) MXPA06010880A (https=)
NO (1) NO339495B1 (https=)
NZ (2) NZ585606A (https=)
PL (1) PL1732929T3 (https=)
PT (1) PT1732929E (https=)
RS (1) RS51742B (https=)
RU (1) RU2380370C2 (https=)
SI (1) SI1732929T1 (https=)
SK (1) SK287994B6 (https=)
TW (1) TWI352704B (https=)
UA (1) UA91189C2 (https=)
WO (1) WO2005090357A1 (https=)
ZA (1) ZA200607388B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101085979B1 (ko) * 2004-03-23 2011-11-22 닛산 가가쿠 고교 가부시키 가이샤 항부정맥제로 사용되는 삼환계 벤조피란 화합물
AU2007225765B2 (en) 2006-03-10 2012-05-24 Nissan Chemical Industries, Ltd. Process for producing optically active chromene oxide compound
WO2010018867A1 (ja) * 2008-08-14 2010-02-18 日産化学工業株式会社 ジ置換ベンゾピラン化合物
RU2523279C2 (ru) * 2009-04-30 2014-07-20 Ниссан Кемикал Индастриз, Лтд. Новая кристаллическая форма соединения трициклического бензопирана и способ его производства
LT2445502T (lt) 2009-06-25 2017-09-25 Alkermes Pharma Ireland Limited Heterocikliniai junginiai, skirti neurologinių ir fiziologinių susirgimų gydymui
WO2014050613A1 (ja) * 2012-09-27 2014-04-03 日産化学工業株式会社 含窒素複素環n-オキシド化合物の製造方法
CN104507949B (zh) * 2012-09-27 2017-07-28 日产化学工业株式会社 高纯度的含氮杂环化合物的制造方法
EP3026047A4 (en) * 2013-07-25 2017-05-17 Nissan Chemical Industries, Ltd. Method for producing heterocyclic compound
EP3567044A4 (en) * 2017-01-06 2020-06-10 Korea University Research and Business Foundation, Sejong Campus INNOVATIVE CHINOLINONE DERIVATIVE AND PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF ALLERGIC DISEASES LIKE ASTHMA OR ATOPIA THEREFORE AS AN ACTIVE SUBSTANCE
EP3761983A1 (en) 2018-03-05 2021-01-13 Alkermes Pharma Ireland Limited Aripiprazole dosing strategy
CN108727261B (zh) * 2018-06-21 2021-09-24 济南大学 一种硝基取代喹那啶的制备方法
EP3903882B1 (en) * 2018-12-28 2025-05-21 Osaka University Therapeutic agent for inherited bradyarrhythmia
RU2754610C1 (ru) 2020-04-14 2021-09-03 Георгий Викторович ТЕЦ Препарат для лечения заболеваний, вызванных бактериями
CN115916201B (zh) * 2020-06-26 2024-09-17 国立大学法人大阪大学 药剂诱发性心动过缓及心动过缓性心律失常治疗药

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0327127A1 (en) * 1988-02-03 1989-08-09 Nissan Chemical Industries Ltd. Pyranobenzoxadiazole derivatives, preparation, use and compositions comprising them
EP0409165A2 (en) * 1989-07-17 1991-01-23 Nissan Chemical Industries Ltd. Process for the optical resolution of pyranobenzoxadiazole compounds
EP0488107A2 (en) * 1990-11-26 1992-06-03 E.R. SQUIBB & SONS, INC. Tricyclic benzodiazole analogs and their use in the treatment of cardiovascular disorders
WO1995034547A1 (en) * 1994-06-10 1995-12-21 Smithkline Beecham Plc C-4 amide substituted compounds and their use as therapeutic agents
EP0693283A1 (en) * 1993-04-02 1996-01-24 Nissan Chemical Industries, Limited Heart failure remedy
CN1169429A (zh) * 1996-05-15 1998-01-07 赫彻斯特股份公司 氨磺酰-取代的苯并二氢吡喃,其制法,作为药物或诊断剂的应用及含有它的药物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZM7682A1 (en) 1981-09-25 1983-05-23 Beecham Group Plc Active compounds
JPS5867683U (ja) 1981-10-28 1983-05-09 株式会社ナムコ 歩行ロボツト
JP2658198B2 (ja) * 1988-06-23 1997-09-30 日産化学工業株式会社 ピラノベンゾトリアゾール誘導体
JP2876712B2 (ja) * 1989-07-17 1999-03-31 日産化学工業株式会社 光学活性ピラノベンゾオキサジアゾール誘導体
JPH07300414A (ja) * 1993-04-02 1995-11-14 Nissan Chem Ind Ltd 心不全治療薬
JP2734457B2 (ja) 1994-02-23 1998-03-30 日産化学工業株式会社 不斉エポキシ化反応
US6486178B1 (en) 1998-06-03 2002-11-26 Nissan Chemical Industries, Ltd. Indane derivatives
AU5444499A (en) 1998-09-01 2000-03-21 Nissan Chemical Industries Ltd. Benzoxazine derivatives
WO2000058300A1 (en) 1999-03-25 2000-10-05 Nissan Chemical Industries, Ltd. Chroman derivatives
HUP0202690A3 (en) * 1999-09-17 2005-02-28 Nissan Chemical Ind Ltd Benzopyran derivative having antiarrhytmic activity
US6555574B1 (en) 1999-09-24 2003-04-29 Nissan Chemical Industries, Ltd. 4-oxybenzopyran derivative
WO2001025224A1 (en) 1999-10-05 2001-04-12 Nissan Chemical Industries, Ltd. 4-oxybenzopyran derivative
TW589305B (en) 2001-02-14 2004-06-01 Nissan Chemical Ind Ltd 4-aminobenzopyran derivatives
HUP0400362A3 (en) 2001-06-25 2007-05-29 Nissan Chemical Ind Ltd Substituted benzopyran derivetives against arrhythmia
WO2003014113A1 (en) 2001-08-06 2003-02-20 Glenmark Pharmaceuticals Limited Novel benzopyran compounds and process for their preparation and use
KR101085979B1 (ko) * 2004-03-23 2011-11-22 닛산 가가쿠 고교 가부시키 가이샤 항부정맥제로 사용되는 삼환계 벤조피란 화합물

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0327127A1 (en) * 1988-02-03 1989-08-09 Nissan Chemical Industries Ltd. Pyranobenzoxadiazole derivatives, preparation, use and compositions comprising them
EP0409165A2 (en) * 1989-07-17 1991-01-23 Nissan Chemical Industries Ltd. Process for the optical resolution of pyranobenzoxadiazole compounds
EP0488107A2 (en) * 1990-11-26 1992-06-03 E.R. SQUIBB & SONS, INC. Tricyclic benzodiazole analogs and their use in the treatment of cardiovascular disorders
EP0693283A1 (en) * 1993-04-02 1996-01-24 Nissan Chemical Industries, Limited Heart failure remedy
WO1995034547A1 (en) * 1994-06-10 1995-12-21 Smithkline Beecham Plc C-4 amide substituted compounds and their use as therapeutic agents
CN1169429A (zh) * 1996-05-15 1998-01-07 赫彻斯特股份公司 氨磺酰-取代的苯并二氢吡喃,其制法,作为药物或诊断剂的应用及含有它的药物

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JP特开平2-4791A 1990.01.09
Wai N. Chan, et al..Conformational preference of the 6-acetyl group in novel anticonvulsant trans 4S-benzamido-benzo[b]pyran-3R-ols.Bioorganic & Medicinal Chemistry Letters.1997,7(12),1573-1576. *

Also Published As

Publication number Publication date
US20080004262A1 (en) 2008-01-03
CY1111250T1 (el) 2015-06-11
AU2005223612B2 (en) 2010-06-24
KR101085979B1 (ko) 2011-11-22
CA2558139C (en) 2012-01-17
NZ549570A (en) 2010-08-27
JP2007530436A (ja) 2007-11-01
DK1732929T3 (da) 2010-12-20
RU2380370C2 (ru) 2010-01-27
CN1934116B (zh) 2012-10-10
WO2005090357A1 (en) 2005-09-29
JP4840594B2 (ja) 2011-12-21
US7652008B2 (en) 2010-01-26
CN102190661A (zh) 2011-09-21
RS51742B (sr) 2011-10-31
US7964623B2 (en) 2011-06-21
CA2558139A1 (en) 2005-09-29
AU2010202900B2 (en) 2011-10-27
CZ2006598A3 (cs) 2006-11-15
TW200600509A (en) 2006-01-01
ES2353021T3 (es) 2011-02-24
SK50792006A3 (sk) 2007-09-06
AU2005223612A1 (en) 2005-09-29
SK287994B6 (sk) 2012-09-03
EG27163A (en) 2015-08-24
IL177950A0 (en) 2006-12-31
PT1732929E (pt) 2010-12-21
KR20070009638A (ko) 2007-01-18
CN102190661B (zh) 2013-07-31
UA91189C2 (en) 2010-07-12
ZA200607388B (en) 2008-07-30
RU2006137284A (ru) 2008-04-27
HRP20110005T1 (hr) 2011-02-28
KR101019402B1 (ko) 2011-03-07
KR20100130249A (ko) 2010-12-10
NO20064819L (no) 2006-10-23
NZ585606A (en) 2011-11-25
CN1934116A (zh) 2007-03-21
MXPA06010880A (es) 2006-12-15
DE602005024245D1 (de) 2010-12-02
EP1732929B1 (en) 2010-10-20
IL177950A (en) 2013-04-30
SI1732929T1 (sl) 2010-12-31
ATE485299T1 (de) 2010-11-15
TWI352704B (en) 2011-11-21
PL1732929T3 (pl) 2011-04-29
AU2010202900A1 (en) 2010-07-29
HK1099299A1 (en) 2007-08-10
EP1732929A1 (en) 2006-12-20
BRPI0508768A (pt) 2007-02-27
US20100069374A1 (en) 2010-03-18
CN101429200A (zh) 2009-05-13
NO339495B1 (no) 2016-12-19

Similar Documents

Publication Publication Date Title
CN101429200B (zh) 用作抗心律失常剂的三环苯并吡喃化合物
CN108699038B (zh) 作为Rock抑制剂的螺环庚烷水杨酸酰胺和相关化合物
ES2780699T3 (es) Amidas de piperidina fusionadas útiles como moduladores de canales iónicos
WO2002074769A1 (en) Drugs containing triazaspiro[5.5]undecane derivatives as the active ingredient
CN108467369A (zh) 作为激酶抑制剂的联芳基酰胺化合物
ES2887087T3 (es) Sulfonas tricíclicas como moduladores ROR gamma
JP2019537594A (ja) アルファvインテグリン阻害剤としての3−置換プロピオン酸
CN110636843A (zh) 作为共价多发性内分泌腺瘤蛋白抑制剂的哌啶
KR20200136958A (ko) 공유 메닌 억제제로서의 피페리딘 화합물
CN115667226B (zh) 作为egfr抑制剂的三环化合物
CN106459033B (zh) 作为间变性淋巴瘤酶(alk)抑制剂的吲哚并喹诺酮类化合物
CN103180312B (zh) 用于治疗或预防因血清素、去甲肾上腺素或多巴胺的神经传导的降低所导致的紊乱的杂环化合物
WO2025247396A1 (zh) 杂环类衍生物及其制备方法和用途
HK40077537A (en) Substituted tricyclic amides, analogues thereof, and methods using same
HK1099299B (en) Tricyclic benzopyran compound as anti-arrhythmic agents

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CP01 Change in the name or title of a patent holder

Address after: Tokyo, Japan

Patentee after: NISSAN CHEMICAL INDUSTRIES, Ltd.

Address before: Tokyo, Japan

Patentee before: NISSAN CHEMICAL INDUSTRIES, Ltd.

CP01 Change in the name or title of a patent holder
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120530

CF01 Termination of patent right due to non-payment of annual fee